PIH Announces Partnership To Tackle MDR-TB With New Drugs
Partners in Health: A New Partnership to Change MDR-TB Treatment around the World
Partners in Health announces that it has received a four-year, $60 million grant from UNITAID “to bring two new drugs to 17 countries in which MDR-TB [(multidrug-resistant tuberculosis)] poses a significant burden. Called ‘END-TB,’ this project is designed to dramatically expand access to these new drugs globally…” (6/10).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.